President Donald Trump launched TrumpRx, a program to buy cost-effective medicine, at the White House Feb. 5. Here's what to know.
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
FDA Commissioner Marty Makary’s initiative promises ultra-fast reviews for drugs aligning with “national priorities.” ...
The milestone is being celebrated as a “huge moment” for rare disease drug development.
The Consolidated Appropriations Act of 2026, signed by Trump on Feb. 3, includes a provision reinstating the Mikaela Naylon ...
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the ...